At the prestigious Irish Pensions Awards Aviva Life & Pensions once again picked up the Innovation Award. This year we won the award for our Aviva Investors Multi Strategies (AIMS) Target Return Fund.
The outcome-oriented investment approach is truly innovative within the Irish market, and encapsulates everything we do from our investment funds to our product design. The AIMS Target Return Fund was launched in the Irish market in October 2014 and continues to attract very strong inflows with €150m from Irish investors to date (Source: Aviva Investors 26 November 2015). The funds aim is to deliver average annual returns of 5 per cent above the European Central Bank base rate (before charges and tax) over any three year period with a target of less than half the volatility of global equities over the same period.
Since it was launched over a year ago, it has delivered strong returns, with low volatility, low maximum drawdown, low Value at Risk (VaR) and a high Sharpe ratio as you can see from the table below.
AIMS Target Return Fund delivers strong risk adjusted - 22/10/2014 to 26/11/2015
Name | Aviva Investors Multi-Strategy (AIMS) Target Return Fund Gr | New Ireland BNYM Global Real Return S10 | Standard Life Synergy GARS |
Performance | 9.26% | 5.65% | 7.28% |
Annualised Standard Deviation | 4.73 | 6.54 | 6.27 |
Max Drawdown | -2.90% | -5.35% | -4.74% |
VaR Level | -0.97% | -1.31% | -1.16% |
Annualised Sharpe ratio | 1.28 | 0.45 | 0.82 |
Source: MoneyMate Longboat Analytics to 27 November 2015. Based on gross fund performance so this excludes the impact of charges and tax.
The Irish Pensions Awards, which are celebrating their 4th year, experienced the highest number of entries on record, making it an even greater achievement to win this year.
Your support in the success of this fund coupled with the recognition by this award is a further demonstration of how we are leading the agenda to deliver new initiatives that will make a difference for financial brokers, customers’ investments and everyone’s experience of Aviva.